ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
계곡열 시장 규모는 향후 수년간 강력한 성장이 전망될 예정입니다. 예측 기간 동안 예상되는 성장은 원격 의료의 채택 증가, 항진균제 내성에 대한 연구 증가, 백신 개발 자금 증가, 고위험 지역으로의 인구 이동 증가, 항진균제 치료의 가용성 확대와 같은 요인에 기인할 수 있습니다. 이 기간에 예상되는 주요 동향으로서는 기술 혁신, 항진균약 수요의 급증, 백신 개발의 주된 발전, 원격 의료의 계속적 성장, 국경을 넘은 협력 체제의 강화 등을 들 수 있습니다.
곰팡이 포자에 대한 노출 증가는 계곡열 시장의 성장을 이끌 것으로 예측됩니다. 삼림 벌채와 기상 패턴의 변화 등의 요인에 의해 이러한 모포에 노출되는 기회가 증가하고 있으며, 토양이 파괴되어 모포의 방출이 촉진되고 있습니다. 계곡열의 치료는 증상을 완화하고, 합병증을 예방하고, 곰팡이의 증식을 억제함으로써 곰팡이의 모포에 노출된 사람들을 돕고, 결국 회복과 삶의 질을 향상시킵니다. 예를 들어, 2024년 9월 국제감염병학회는 침습성 진균 감염이 매년 약 650만 명에게 영향을 미쳐 약 380만 명이 사망했고, 이 중 약 250만 명이 이러한 감염과 직접적으로 관련된 사망을 초래했다고 보고했습니다.
건강 관리 시설의 성장은 계곡열 시장을 밀어 올릴 것으로 예측됩니다. 건강 관리 시설은 효과적인 건강 관리 서비스를 제공하는 데 필수적인 인프라, 시스템 및 자원을 의미합니다. 원격 의료, 로봇 수술, 인공지능 진단 등의 혁신은 환자의 결과와 업무 효율을 높이기 위해 업그레이드된 시설, 전문 장비 및 개선 된 의료 제공 시스템이 필요하기 때문에 의료 인프라의 확장은 의료 기술의 진보로 추진됩니다. 이 시설은 조기 진단, 항진균 치료, 환자 교육, 증상 관리 및 합병증 예방을 위한 지속적인 치료를 제공하여 계곡 열 치료를 지원합니다. 예를 들어 미국 병원 협회의 보고서에 따르면 미국 병원 수는 2022년 6,093개에서 2024년 6,120개로 증가했습니다. 그 결과, 건강 관리 인프라의 성장이 계곡열 시장의 확대를 뒷받침하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 - 거시경제 시나리오 금리, 인플레이션, 지정학, 신형 코로나 바이러스 감염의 영향과 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 계곡열 PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 성장 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 계곡열 시장 : 성장률 분석
세계의 계곡열 시장 실적 : 규모와 성장(2019-2024년)
세계의 계곡열 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 계곡열 전체 시장(TAM)
제6장 시장 세분화
세계의 계곡열 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
플루코나졸
이트라코나졸
보리코나졸
포사코나졸
기타 치료 유형
세계의 계곡열 시장 : 감염 부위별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
피부
폐
간
뼈
심장
뇌
뇌와 척수를 둘러싸는 막
기타 감염 부위
세계의 계곡열 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
인간
소
양 및 염소
낙타
기타 최종 사용자
세계의 계곡열 시장 : 플루코나졸, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구 플루코나졸
정맥내 플루코나졸
세계의 계곡열 시장 : 이트라코나졸, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
캡슐 이트라코나졸
경구 용액 이트라코나졸
세계의 계곡열 시장 : 보리코나졸, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구 볼리코나졸
정맥내 볼리코나졸
세계의 계곡열 시장 : 포사코나졸, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
경구 현탁액 포사코나졸
서방형 정제 포사코나졸
정맥내 주사 포사코나졸
세계의 계곡열 시장 : 기타 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병용 요법
보조 요법
제7장 지역별/국가별 분석
세계의 계곡열 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 계곡열 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
계곡열 시장 : 경쟁 구도
계곡열 시장 : 기업 프로파일
Merck & Co. Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
Fresenius Kabi : 개요, 제품 및 서비스, 전략 및 재무 분석
Dr. Reddy's Laboratories : 개요, 제품 및 서비스, 전략 및 재무 분석
Horster Life Science : 개요, 제품 및 서비스, 전략 및 재무 분석
Mankind Pharma : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Atom Pharma
Ravoos Laboratories
Casca Remedies
Hema Pharmaceuticals
Globela Pharma
Spansules Pharmatech
Sanes Pharmaceuticals
CDH Chemicals
Sainor Laboratories
Maithili Life Sciences
Stratechem(I) Pvt. Ltd.
Shantam Pharma
Cerata Pharmaceuticals
Aden Healthcare
Kabir Lifesciences
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
계곡열 시장(2029년) : 새로운 기회를 제공하는 국가
계곡열 시장(2029년) : 새로운 기회를 제공하는 부문
계곡열 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
KTH
영문 목차
영문목차
Valley fever, also known as coccidioidomycosis, is a fungal infection that mainly affects the lungs, causing symptoms such as cough, fever, fatigue, and chest pain. In some cases, it can lead to severe complications. The infection is caused by inhaling airborne spores from the coccidioides fungi, which are commonly found in dry, dusty soil and become airborne when the soil is disturbed.
The primary treatment options for valley fever include fluconazole, itraconazole, voriconazole, posaconazole, and others. Fluconazole is an antifungal medication that works by inhibiting the growth of fungi to treat fungal infections. The infection can affect various sites, including the skin, lungs, liver, bones, heart, brain, and the membranes surrounding the brain and spinal cord. These treatments are used for a range of end-users, including humans, cattle, sheep, goats, camels, and others.
The valley fever market research report is one of a series of new reports from The Business Research Company that provides valley fever market statistics, including valley fever industry global market size, regional shares, competitors with a valley fever market share, detailed valley fever market segments, market trends and opportunities, and any further data you may need to thrive in the valley fever industry. This valley fever market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The valley fever market size has grown strongly in recent years. It will grow from $0.99 billion in 2024 to $1.05 billion in 2025 at a compound annual growth rate (CAGR) of 5.8%. The growth during the historic period can be attributed to factors such as the increasing effects of climate change driving the spread of fungal infections, rising research funding for Valley Fever treatments, greater investments in healthcare, growing demand for specialized diagnostic laboratories, and a rising incidence of Valley Fever in non-endemic regions.
The valley fever market size is expected to see strong growth in the next few years. It will grow to $1.29 billion in 2029 at a compound annual growth rate (CAGR) of 5.4%. The projected growth during the forecast period can be attributed to factors such as the increasing adoption of telemedicine, a rise in research on antifungal resistance, growing funding for vaccine development, higher population movement across high-risk areas, and the expanding availability of antifungal treatments. Key trends expected in this period include technological innovations, a surge in demand for antifungal drugs, advancements in vaccine development, the continued growth of telemedicine, and enhanced cross-border collaboration.
The increasing exposure to fungus spores is expected to drive the growth of the valley fever market. Fungus spores are tiny reproductive units produced by fungi that can spread through air, water, or surfaces, allowing the fungus to grow and reproduce in new environments. Exposure to these spores has been rising due to factors such as deforestation and shifting weather patterns, which disrupt the soil and promote the release of spores. This leads to a higher risk of infections such as valley fever, particularly in arid regions where the coccidioides fungus thrives. Valley fever treatments help those exposed to fungal spores by alleviating symptoms, preventing complications, and controlling fungal growth, ultimately improving recovery and quality of life. For example, in September 2024, the International Society for Infectious Diseases reported that invasive fungal infections affect about 6.5 million people annually, causing nearly 3.8 million deaths, with approximately 2.5 million deaths directly related to these infections. Therefore, the rising exposure to fungus spores is fueling the growth of the valley fever market.
The growth of healthcare facilities is anticipated to boost the valley fever market. Healthcare facilities refer to the essential infrastructure, systems, and resources required to provide effective healthcare services. The expansion of healthcare infrastructure is driven by advances in medical technology, as innovations such as telemedicine, robotic surgery, and AI-driven diagnostics require upgraded facilities, specialized equipment, and improved healthcare delivery systems to enhance patient outcomes and operational efficiency. These facilities support the treatment of valley fever by offering early diagnosis, antifungal treatments, patient education, and ongoing care to manage symptoms and prevent complications. For instance, the American Hospital Association reported that in 2024, there were 6,120 hospitals in the United States, up from 6,093 in 2022. As a result, the growth in healthcare infrastructure is driving the expansion of the valley fever market.
Companies in the valley fever market are focusing on developing innovative vaccines to combat the growing threat of fungal infections. These vaccines aim to protect individuals by using advanced scientific methods and manufacturing techniques, which enhance public health and safety. For instance, in August 2024, Anivive Lifesciences Inc., a U.S.-based pet pharmaceutical company, received a contract worth up to $33 million from the National Institute of Allergy and Infectious Diseases (NIAID) to develop a human vaccine for valley fever. The funding will support further manufacturing, formulation, extensive safety testing, and a Phase 1 clinical trial, with the goal of delivering the first vaccine to prevent this serious systemic fungal infection.
Major players in the valley fever market are Merck & Co. Inc., Fresenius Kabi, Dr. Reddy's Laboratories, Horster Life Science, Mankind Pharma, Atom Pharma, Ravoos Laboratories, Casca Remedies, Hema Pharmaceuticals, Globela Pharma, Spansules Pharmatech, Sanes Pharmaceuticals, CDH Chemicals, Sainor Laboratories, Maithili Life Sciences, Stratechem (I) Pvt. Ltd., Shantam Pharma, Cerata Pharmaceuticals, Aden Healthcare, Kabir Lifesciences.
North America was the largest region in the valley fever market in 2024. The regions covered in valley fever report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.
The countries covered in the Valley Fever market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The valley fever market consists of sales of antifungal medications and steroids. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Valley Fever Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on valley fever market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for valley fever ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The valley fever market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Types Of Treatment: Fluconazole; Itraconazole; Voriconazole; Posaconazole; Others Types Of Treatment
2) By Site Of Infection: Skin; Lungs; Liver; Bones; Heart; Brain; Membranes That Surround The Brain And Spinal Cord; Other Sites Of Infection
3) By End-Users: Human; Cattle; Sheep And Goats; Camel; Other End-Users
Sub Segments:
1) By Fluconazole Type: Oral Fluconazole; Intravenous Fluconazole
2) By Itraconazole Type: Capsule Itraconazole; Oral Solution Itraconazole
3) By Voriconazole Type: Oral Voriconazole; Intravenous Voriconazole
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.
Table of Contents
1. Executive Summary
2. Valley Fever Market Characteristics
3. Valley Fever Market Trends And Strategies
4. Valley Fever Market - Macro Economic Scenario Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market
5. Global Valley Fever Growth Analysis And Strategic Analysis Framework
5.1. Global Valley Fever PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Valley Fever Market Growth Rate Analysis
5.4. Global Valley Fever Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Valley Fever Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Valley Fever Total Addressable Market (TAM)
6. Valley Fever Market Segmentation
6.1. Global Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Fluconazole
Itraconazole
Voriconazole
Posaconazole
Others Types Of Treatment
6.2. Global Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Skin
Lungs
Liver
Bones
Heart
Brain
Membranes That Surround The Brain And Spinal Cord
Other Sites Of Infection
6.3. Global Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Human
Cattle
Sheep And Goats
Camel
Other End-Users
6.4. Global Valley Fever Market, Sub-Segmentation Of Fluconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Fluconazole
Intravenous Fluconazole
6.5. Global Valley Fever Market, Sub-Segmentation Of Itraconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Capsule Itraconazole
Oral Solution Itraconazole
6.6. Global Valley Fever Market, Sub-Segmentation Of Voriconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Voriconazole
Intravenous Voriconazole
6.7. Global Valley Fever Market, Sub-Segmentation Of Posaconazole, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Oral Suspension Posaconazole
Delayed-Release Tablets Posaconazole
Intravenous Posaconazole
6.8. Global Valley Fever Market, Sub-Segmentation Of Others Types Of Treatment, By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Combination Therapy
Adjunctive Therapy
7. Valley Fever Market Regional And Country Analysis
7.1. Global Valley Fever Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Valley Fever Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Valley Fever Market
8.1. Asia-Pacific Valley Fever Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Valley Fever Market
9.1. China Valley Fever Market Overview
9.2. China Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Valley Fever Market
10.1. India Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Valley Fever Market
11.1. Japan Valley Fever Market Overview
11.2. Japan Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Valley Fever Market
12.1. Australia Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Valley Fever Market
13.1. Indonesia Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Valley Fever Market
14.1. South Korea Valley Fever Market Overview
14.2. South Korea Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Valley Fever Market
15.1. Western Europe Valley Fever Market Overview
15.2. Western Europe Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Valley Fever Market
16.1. UK Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Valley Fever Market
17.1. Germany Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Valley Fever Market
18.1. France Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Valley Fever Market
19.1. Italy Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Valley Fever Market
20.1. Spain Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Valley Fever Market
21.1. Eastern Europe Valley Fever Market Overview
21.2. Eastern Europe Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Valley Fever Market
22.1. Russia Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Valley Fever Market
23.1. North America Valley Fever Market Overview
23.2. North America Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Valley Fever Market
24.1. USA Valley Fever Market Overview
24.2. USA Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Valley Fever Market
25.1. Canada Valley Fever Market Overview
25.2. Canada Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Valley Fever Market
26.1. South America Valley Fever Market Overview
26.2. South America Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Valley Fever Market
27.1. Brazil Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Valley Fever Market
28.1. Middle East Valley Fever Market Overview
28.2. Middle East Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Valley Fever Market
29.1. Africa Valley Fever Market Overview
29.2. Africa Valley Fever Market, Segmentation By Types Of Treatment, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Valley Fever Market, Segmentation By Site Of Infection, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Valley Fever Market, Segmentation By End-Users, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Valley Fever Market Competitive Landscape And Company Profiles
30.1. Valley Fever Market Competitive Landscape
30.2. Valley Fever Market Company Profiles
30.2.1. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Fresenius Kabi Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis
30.2.4. Horster Life Science Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Mankind Pharma Overview, Products and Services, Strategy and Financial Analysis
31. Valley Fever Market Other Major And Innovative Companies
31.1. Atom Pharma
31.2. Ravoos Laboratories
31.3. Casca Remedies
31.4. Hema Pharmaceuticals
31.5. Globela Pharma
31.6. Spansules Pharmatech
31.7. Sanes Pharmaceuticals
31.8. CDH Chemicals
31.9. Sainor Laboratories
31.10. Maithili Life Sciences
31.11. Stratechem (I) Pvt. Ltd.
31.12. Shantam Pharma
31.13. Cerata Pharmaceuticals
31.14. Aden Healthcare
31.15. Kabir Lifesciences
32. Global Valley Fever Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Valley Fever Market
34. Recent Developments In The Valley Fever Market
35. Valley Fever Market High Potential Countries, Segments and Strategies
35.1 Valley Fever Market In 2029 - Countries Offering Most New Opportunities
35.2 Valley Fever Market In 2029 - Segments Offering Most New Opportunities
35.3 Valley Fever Market In 2029 - Growth Strategies
